India's cheap weight-loss drugs could reshape global obesity fight
News
Archived
•
March 18, 2026
•
2 views
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Source: http://feeds.bbci.co.uk/news/world/rss.xml - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"Output is a realization of Input."
